A detailed history of Advisor Resource Council transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Advisor Resource Council holds 519 shares of VRTX stock, worth $260,771. This represents 0.08% of its overall portfolio holdings.

Number of Shares
519
Holding current value
$260,771
% of portfolio
0.08%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 31, 2024

BUY
$460.0 - $505.78 $238,740 - $262,499
519 New
519 $241,000
Q2 2022

Jul 27, 2022

BUY
$234.96 - $292.55 $172,225 - $214,439
733 Added 1062.32%
802 $226,000
Q2 2021

Aug 13, 2021

BUY
$187.49 - $221.1 $12,936 - $15,255
69 New
69 $13,000

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $129B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Advisor Resource Council Portfolio

Follow Advisor Resource Council and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Resource Council, based on Form 13F filings with the SEC.

News

Stay updated on Advisor Resource Council with notifications on news.